Article
Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity.
American journal of human genetics - 5 Apr 2018
Zarouchlioti Christina, Sanchez-Pintado Beatriz, Hafford Tear Nathaniel J, Klein Pontus, Liskova Petra, Dulla Kalyan, Semo Ma'ayan, Vugler Anthony A, Muthusamy Kirithika, Dudakova Lubica, Levis Hannah J, Skalicka Pavlina, Hysi Pirro, Cheetham Michael E, Tuft Stephen J, Adamson Peter, Hardcastle Alison J, Davidson Alice E
Abstract excerpt
Fuchs endothelial corneal dystrophy (FECD) is a common disease for which corneal transplantation is the only treatment option in advanced stages, and alternative treatment strategies are urgently required. Expansion (≥50 copies) of a non-coding trinucleotide repeat in TCF4 confers >76-fold risk for FECD in our large cohort of affected individuals. An FECD subject-derived corneal endothelial cell (CEC) model was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
